ISHLT Voices

In this episode of the ISHLT Voices podcast, hosted by Kamada, you'll hear experts discuss different cytomegalovirus (CMV) prophylaxis approaches in high-risk lung transplant patients.   Fernando Torres, MD   Professor of Internal Medicine Clinical Chief, Division of Pulmonary/Critical Care UT Southwestern Medical Center Dallas, TX USA   Amir M. Emtiazjoo, MD, MSc   Associate Professor of Medicine...

In this episode of the ISHLT Voices podcast, hosted by Natera, you'll hear transplant cardiologists explore the evolving landscape of post-heart transplant care, zeroing in on the transformative shift from traditional, invasive biopsies to cutting-edge noninvasive molecular diagnostics—particularly cell-free DNA technologies. Brent Lampert, DO Medical Director, Transplant Cardiologist The Ohio Sta...

In this episode of the ISHLT Voices podcast, hosted by Natera , you'll hear a discussion on the need for noninvasive surveillance options for single lung transplantation and the role that the Prospera Lung donor derived cell free DNA (dd-cfDNA) test can play. There are inherent, increased risks and challenges associated with management of single lung transplantation over double lung. Monitoring th...

Presented by Kamada In this episode of the ISHLT Voices podcast, hosted by Kamada , you'll hear a discussion on the utilization of Cytomegalovirus Immune Globulin (CMV IgG) in solid organ transplantation (SOT). First, a focused overview of CMV IgG, including what they are, how they are made, and their role in SOT. The experts describe the differences between hyperimmune globulins like CMV IgG and...

Presented by Natera Natera returns with another ISHLT Voices podcast. Post-transplant monitoring with noninvasive donor derived cell free DNA (dd-cfDNA) has been growing in popularity and usage with several transplant centers significantly reducing surveillance biopsies in favor of a single blood test. But, as with all new technology, there are outstanding questions to understand how and why the t...

Presented by Zambon USA ISHLT Voices returns with another podcast presented by  Zambon USA exploring bronchiolitis obliterans syndrome (BOS). BOS is one of the most common forms of chronic lung transplant rejection, and in part three of this series, experts take a deep dive into CLAD phenotype differentiation, current gaps in diagnosis and management of BOS, emerging treatment strategies, and last...

Presented by Natera In this episode of the ISHLT Voices podcast, Dr. Shri Deshpande, a cardiologist at the National Children's Hospital in Washington, DC USA, discusses his work on improving the care of pediatric heart transplant patients.  Dr. Deshpande's research focuses on the use of cell-free DNA in monitoring transplant recipients for rejection. He explains that cell-free DNA, released when c...

Presented by Zambon USA ISHLT Voices returns with another podcast presented by  Zambon USA exploring bronchiolitis obliterans syndrome (BOS). BOS is one of the most common forms of chronic lung transplant rejection, and in part two of this series, experts take a deep dive into the role of lung function monitoring post-transplant for the detection of chronic lung transplant rejection, specifically...

Presented by Zambon USA The first episode of ISHLT Voices is now live! This podcast, presented by Zambon USA , explores bronchiolitis obliterans syndrome (BOS), one of the most common forms of chronic lung transplant rejection. Despite advances in surgical techniques, BOS remains the Achilles heel of lung transplants. In this podcast, experts address critical questions regarding diagnosis, managem...